Tafamidis

Intervention2 papersPubChem 11001318ChEBI 78538

Humans2

Latest

5

Cardiology and TherapyHumans13 Sep

Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy

AmyloidHumans10 Sep

Frailty is a mortality risk factor in tafamidis-treated patients with transthyretin cardiac amyloidosis

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Use of Contemporary Cardiometabolic Therapies in Cardiac Amyloidosis Treated with Tafamidis: A Real-World Propensity-Matched Analysis

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Sex-related differences in clinical outcomes among heart failure patients with cardiac amyloidosis on SGLT2i therapy

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Combination Therapy with SGLT2 Inhibitors and Tafamidis Improves Outcomes More Than Tafamidis Alone in ATTR Cardiac Amyloidosis